Related Experiment Video
Updated: Jul 10, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Thyroid carcinoma--differentiated, poorly differentiated and anaplastic carcinoma]
Kennichi Kakudo1, Yanhua Bai, Yaqiong Li
1Department of Pathology, Wakayama Medical University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 21, 2007
Summary
The 2004 World Health Organization classification redefined poorly differentiated thyroid carcinoma, impacting its incidence and prognosis. This aggressive cancer now accounts for 1-5% of thyroid malignancies.
Area of Science:
- Endocrinology
- Pathology
- Oncology
Context:
- The classification of thyroid carcinomas has evolved.
- The 2004 World Health Organization (WHO) edition introduced poorly differentiated carcinoma as a distinct entity.
- Histological criteria for this diagnosis were revised.
Purpose:
- To detail the revised histological criteria for poorly differentiated thyroid carcinoma.
- To analyze the impact of the new classification on the incidence and prognosis of this thyroid cancer.
- To compare the outcomes under the new WHO definition versus previous classifications.
Summary:
- Poorly differentiated thyroid carcinoma was newly defined in the 2004 WHO classification.
- Revised criteria include necrosis and increased mitoses, alongside Sakamoto's original solid, trabecular, and schirrhous growth patterns.
- This revised definition impacts the carcinoma's incidence (1-5% of thyroid malignancies) and indicates a more aggressive outcome.
Impact:
- The 2004 WHO classification significantly altered the understanding of poorly differentiated thyroid carcinoma's incidence.
- The revised criteria highlight a more aggressive clinical behavior compared to previous definitions.
- This reclassification is crucial for accurate diagnosis, treatment planning, and prognostic assessment of thyroid cancer.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

